Quinagolide

This classification denotes an antipsychotic agent with the molecular formula C20H33N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80Q9QWN15M, chemically known as sulfamide, n,n-diethyl-n-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)-, (3-alpha,4a-alpha,10a-beta)-(+-)- but generally known as quinagolide, which bears US NIH Compound Identifier 55645. European Medicines Agency schedules Quinagolide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10199MIG. The term QUINAGOLIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules quinagolide in its Anatomical Therapeutic Chemical (ATC) Classification. QUINAGOLIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quinagolide under HS 29339990 and SITC 51577. As of Q4 2014, QUINAGOLIDE remains the US FDA Preferred Term for this commodity. Quinagolide bears US NLM identifiers UMLS ID C0256089 and NCI Concept Code C73310. SMILES: S(=O)(=O)(NC1CC2C(N(C1)CCC)CC1C(C2)C(O)CCC1)N(CC)CC.